A Study to Evaluate the Efficacy of a Postbiotic Supplement on Menopausal Symptoms in Premenopausal Women

Part of paid clinical trials in Dallas, Texas.

Sponsor
Able Biolabs, LLC
Study ID
NCT07570043
Status
Completed

Conditions

Eligibility Criteria

Sex
FEMALE
Age
35 Years - 55 Years
Healthy Volunteers
Accepted

Interventions

  • Supplement — DIETARY_SUPPLEMENT
    Active supplement
  • Placebo — OTHER
    Inactive supplement

Study Details

The goal of this consumer health study is to evaluate the effect of resW™ Perimenopause Postbiotic on menopausal symptom severity, menopause-related quality of life, and selected microbiome-related outcomes in generally healthy perimenopausal women aged 35 to 55 years. Participants will be randomized to receive either the active supplement or placebo daily for 4 weeks. Participants will complete electronic questionnaires at baseline and during the study. A predefined subset of participants will also complete stool and vaginal sample collection at baseline and Week 4.

Key Dates

Start date
Mar 4, 2026
Status verified
May 2026
Primary completion
May 15, 2026
Completion
May 27, 2026

Study Design

Enrollment
80 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Placebo Comparator: Placebo
  • Experimental: Supplement

Primary Outcome Measure

Change in Greene Climacteric Scale total score from baseline to Week 4 [ Time Frame: Baseline to Week 4 ]

Locations (1)

FacilityCityStateZIPSite coordinators
Able Biolabs LLCDallasTexas75247-

Find similar trials in Dallas, TX

By condition
Menopause
By specialty
Women's healthFertility
By research site
Able Biolabs LLC· Dallas, TX

Related Studies